Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAN 2021 | Perspectives on gene therapy for neuromuscular disorders (NMD)

Jerry Mendell, MD, FAAN, Nationwide Children’s Hospital & Ohio State University, Columbus, OH, discusses the open opportunities in the gene therapy field for neurology and neuromuscular diseases. Prof. Mendell sees a good opportunity for the development of treatments for many diseases in the coming years. This interview took place during the American Academy of Neurology (AAN) 2021 Annual Meeting.


Prof. Mendell reports the following disclosures:
Consultant for Sarepta therapeutics, Novartis Inc, Vertex Inc